Seroatlas · Human Serome Atlas

TMLHE

Trimethyllysine dioxygenase, mitochondrial

Also known as: BBOX2, FLJ10727, TMLH, TMLH_HUMAN, XAP130

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
Q9NVH6
Gene
TMLHE
Ensembl
ENSG00000185973
Chromosome
X
Canonical length
421 aa
Protein class
Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins
Subcellular location
Mitochondria
Quaternary structure
Homodimer

OverviewNCBI Gene

This gene encodes the protein trimethyllysine dioxygenase which is the first enzyme in the carnitine biosynthesis pathway. Carnitine play an essential role in the transport of activated fatty acids across the inner mitochondrial membrane. The encoded protein converts trimethyllysine into hydroxytrimethyllysine. A pseudogene of this gene is found on chromosome X. Alternate splicing results in multiple transcript variants.[provided by RefSeq, May 2010]

Canonical amino-acid sequenceUniProt

421 residues, UniProt reviewed canonical sequence.

>Q9NVH6|TMLHE
     1  MWYHRLSHLH SRLQDLLKGG VIYPALPQPN FKSLLPLAVH WHHTASKSLT CAWQQHEDHF
    61  ELKYANTVMR FDYVWLRDHC RSASCYNSKT HQRSLDTASV DLCIKPKTIR LDETTLFFTW
   121  PDGHVTKYDL NWLVKNSYEG QKQKVIQPRI LWNAEIYQQA QVPSVDCQSF LETNEGLKKF
   181  LQNFLLYGIA FVENVPPTQE HTEKLAERIS LIRETIYGRM WYFTSDFSRG DTAYTKLALD
   241  RHTDTTYFQE PCGIQVFHCL KHEGTGGRTL LVDGFYAAEQ VLQKAPEEFE LLSKVPLKHE
   301  YIEDVGECHN HMIGIGPVLN IYPWNKELYL IRYNNYDRAV INTVPYDVVH RWYTAHRTLT
   361  IELRRPENEF WVKLKPGRVL FIDNWRVLHG RECFTGYRQL CGCYLTRDDV LNTARLLGLQ
   421  A

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against TMLHE can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Intracellular
Secreted
No
Transmembrane segments
0
Mean surface accessibility (rSASA)
0.31
Highest tissue expression
31 nTPM

Expression across tissuesHPA

Tissue

  • tongue: 31 nTPM
  • skeletal muscle: 30 nTPM
  • heart muscle: 24 nTPM
  • parathyroid gland: 18 nTPM
  • liver: 18 nTPM
  • kidney: 16 nTPM

Single-cell type

  • myonuclei: 875 nCPM
  • cardiomyocytes: 352 nCPM
  • adipocytes: 218 nCPM
  • renal collecting duct intercalated cells: 110 nCPM
  • neutrophils: 109 nCPM
  • epicardial cells: 102 nCPM

Immune cell

  • non-classical monocyte: 22 nTPM
  • neutrophil: 18 nTPM
  • intermediate monocyte: 15 nTPM
  • eosinophil: 15 nTPM
  • myeloid DC: 13 nTPM
  • classical monocyte: 13 nTPM

Brain region

  • white matter: 21 nTPM
  • cerebellum: 18 nTPM
  • medulla oblongata: 18 nTPM
  • spinal cord: 18 nTPM
  • midbrain: 17 nTPM
  • choroid plexus: 17 nTPM

DiseaseUniProt · ClinVar · IEDB · PubMed

Four sources answering four different questions about TMLHE.

Disease | AllUniProt

Conditions TMLHE is implicated in, by any mechanism.

Disease | GeneticClinVar

6 pathogenic / likely-pathogenic of 149 ClinVar records.

Conditions with pathogenic or likely-pathogenic variants.

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
1.18
gnomAD pLI
0
gnomAD missense Z
0.64
DepMap mean gene effect
0.12
DepMap dependency class
none

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads TMLHE as an antibody target. Whether an autoantibody or antibody against TMLHE could matter depends on whether native TMLHE is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

TMLHE is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.

Annotation status

The present source text does not explicitly label TMLHE as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/TMLHE. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...